22.06.2024 | Global Health Services Research
From Input to Impact: Clinical Significance of Data Quality in the National Cancer Database
verfasst von:
Samantha Warwar, MD, MS, Swati Kulkarni, MD, FACS
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 9/2024
Einloggen, um Zugang zu erhalten
Excerpt
The National Cancer Database (NCDB) is a hospital-based cancer registry that collects data from approximately 1500 Commission on Cancer (CoC)-accredited hospitals.
1 It collects data for roughly 1.5 million newly diagnosed cancers annually and represents 75 different cancer sites.
1 Implemented in 1989, the NCDB serves as a comprehensive source of oncologic data designed to improve cancer care by supporting clinical outcomes research and quality improvement.
2,3 As of 2021, more than 1300 publications cite the use of NCDB participant user files.
4 A distinctive feature of the NCDB is the availability of treatment data. Compared with the Surveillance, Epidemiology, and End Results (SEER), a population-based program, the NCDB provides more comprehensive information about the type (e.g., surgery, radiation therapy, chemotherapy) and sequence of cancer treatment, which is of increasing importance as more patients receive multimodality therapy for their initial cancer diagnosis. Another distinguishing feature of the NCDB is the shorter interval of time from data abstraction to data availability in the NCDB, which benefits researchers interested in studying treatment trends and patterns over time.
2,3 …